Pharmacoepidemiology & Drug Safety Journal Issues Research Articles in November 2021 Edition

BETHESDA, Maryland, Oct. 6 -- Pharmacoepidemiology and Drug Safety, a journal that says it provides an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology from the International Society for Pharmacoepidemiology, published research articles, including the following topics, in its November 2021 edition:

ORIGINAL ARTICLES:

* Association between inhaled corticosteroid use and COVID-19 outcomes

* Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

* Prescriptions of analgesics during chronic cancer disease trajectories: A complete national cohort study

* Increasing rates of buprenorphine diversion in the United States, 2002 to 2019

* Utilization of opioid versus non-opioid analgesics in Medicaid and CHIP enrolled children with current asthma

* Prevalence and distribution of high-risk prescription opioid use in the United States, 2011-2016

* Prevalence of prescription opioid use during pregnancy in eight US health plans during 2001-2014

* Trend changes of national zolpidem users and exposure cases after FDA drug safety communications

* Use of sedating medications around nursing home admission in Denmark

* Prevalence and quality of antihypertensive therapy among hypertension patients enrolled in the Ghana National Health Insurance Scheme

* Proton pump inhibitors long term use-trends and patterns over 15years of a large health maintenance organization

The November 2021 edition of the Pharmacoepidemiology and Drug Safety Journal can be viewed at https://onlinelibrary.wiley.com/toc/10991557/2021/30/11. The journal is published by John Wiley & Sons.